The stock decreased 0.54% or $0.41 during the last trading session, reaching $75.24. About 181,827 shares traded. Union Bankshares Corporation (UBSH) has risen 21.53% since January 11, 2017 and is uptrending. It has outperformed by 7.11% the S&P500.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide.
Toth Financial Advisory Corp increased its stake in Abbvie Inc (ABBV) by 7.94% based on its latest 2017Q3 regulatory filing with the SEC. Jp Marvel Advisors Limited Liability Company owns 77,919 shares or 2.2% of their United States portfolio. The Heritage Investors Management Corp holds 98,616 shares with $8.76 million value, down from 105,234 last quarter. M&R Follow-On Fund Management Lp who had been investing in Mplx Lp for a number of months, seems to be bullish on the $15.96 billion market cap company. The stock decreased 0.29% or $0.25 during the last trading session, reaching $85.61. About 1.57M shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since January 10, 2017 and is uptrending. It has underperformed by 4.16% the S&P500. A 11 analysts rate it as either a buy or a strong buy, while 0 believe that investors should either steer clear of (NYSE:ABBV) or, if they already own its stock, sell it. Therefore 52% are positive. Lincoln National reported 0.08% of its portfolio in AbbVie Inc. The company was maintained on Friday, October 23 by UBS. The firm has "Buy" rating by H.C. Wainwright given on Friday, December 8. Abbvie Inc now has $159.44B valuation. (NYSE:ABBV) was sold by Schumacher Laura J on Thursday, December 14. SunTrust maintained the shares of ABBV in report on Monday, October 16 with "Buy" rating. The firm has "Outperform" rating given on Monday, October 30 by Leerink Swann. They now have a buy rating on the stock. AbbVie comprises 1.3% of Blue Granite Capital LLC's portfolio, making the stock its 29th biggest position. Cowen restated a "hold" rating and set a $95.00 price target (up previously from $70.00) on shares of AbbVie in a report on Monday, September 11th.
Analysts await AbbVie Inc. (NYSE:ABBV) rating on Monday, October 30. Citigroup has "Buy" rating and $33 target.More news: Reading East MP Matt Rodda appointed to shadow cabinet
Investors of record on Friday, January 12th will be paid a dividend of $0.71 per share. Blue Granite Capital LLC's holdings in AbbVie were worth $1,822,000 at the end of the most recent reporting period. The ratio fall, as 594 investment managers increased and opened new positions, while 695 reduced and sold their stakes in Abbvie Inc.
There are 1,864 institutional holders with active positions, accounting for 1.11 billion shares in total. Wellington Mngmt Gp Inc Llp stated it has 0% in AbbVie Inc. Following the transaction, the chairman now owns 492,030 shares in the company, valued at $46,255,740.30. This is a boost from AbbVie's previous quarterly dividend of $0.64. The average 1-year price target for (ABBV) reveals an average price target of $100.75 per share. Systematic Mngmt Lp holds 9,300 shares. Federated Investors Pa reported 10.64 million shares. Ccm Inv Advisers Limited Liability Corporation reported 2.3% stake. (NYSE:ABBV) to report earnings on January, 26.
AbbVie Inc. (ABBV) pulled off a 0.75 percent gain and now trades for $100.24.
AbbVie (NYSE ABBV) opened at $99.27 on Monday. (NYSE:ABBV). Donaldson Cap Management Limited Co, a Indiana-based fund reported 417,872 shares. Mrj Capital has invested 2.12% in AbbVie Inc.More news: Golden Globes: Complete Winners List
Now focusing our attention on earnings data, we were able to identify that EPS consensus estimate for AbbVie Inc. It also reduced its holding in Exxon Mobil Corp (NYSE:XOM) by 6,746 shares in the quarter, leaving it with 18,195 shares, and cut its stake in Catalent Inc (NYSE:CTLT).
More notable recent AbbVie Inc. Following the completion of the sale, the insider now owns 81,287 shares of the company's stock, valued at approximately $7,360,537.85. Ballentine Prtnrs Llc reported 47,481 shares stake.
Investors are definitely paying attention to what analysts over at Wall Street are now thinking about the shares of D.R. Horton, Inc. The other 12, though not evenly; between analysts who think you should buy BorgWarner Inc. versus those who think you should sell it. (NYSE:ABBV) to report earnings on January, 26. AbbVie's revenue for the quarter was up 8.8% compared to the same quarter a year ago. ABBV's profit will be $2.28 billion for 17.35 P/E if the $1.43 EPS becomes a reality. After $1.41 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 1.42% EPS growth.
Since July 31, 2017, it had 0 buys, and 8 selling transactions for $45.57 million activity. Another trade for 6,699 shares valued at $589,512 was made by Michael Robert A. on Thursday, September 28. Veritable Ltd Partnership owns 9,534 shares for 0.01% of their portfolio. Seven analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the stock. Therefore 65% are positive. Lipocine Inc had 11 analyst reports since July 22, 2015 according to SRatingsIntel. The company was initiated on Wednesday, April 6 by Societe Generale. The rating was initiated by Stifel Nicolaus on Tuesday, February 23 with "Hold". The company was maintained on Monday, July 17 by Jefferies. RBC Capital Markets maintained Citigroup Inc. (NYSE:OKE) on Tuesday, August 1 with "Hold" rating. The rating was maintained by BMO Capital Markets on Wednesday, June 7 with "Hold". The rating was maintained by Piper Jaffray with "Buy" on Thursday, September 28.More news: Messi double helps Barca reach King's Cup quarter-finals
- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.